Bioinformatics analysis identifies ZBTB16 as a potential immune biomarker for lung cancer and pan-cancer
Three validation methods and pan cancer analysis all showed that the expression of ZBTB16 was reduced in lung cancer and various cancers, which may be a key gene for the occurrence and development of lung cancer and various cancers.
Authors
- Xinmin Li (ORCID: https://orcid.org/0000-0001-9137-3598)
- Yong Li (ORCID: https://orcid.org/0000-0002-0330-657X)
- Danfei Shi
- Di Zhu
- Yunxiang Cai
Institutions
- Huzhou Normal University (CN)
- Third People's Hospital of Huzhou (CN)
- First People's Hospital of Chongqing (CN)
Publication Details
- Journal
- Frontiers in Genetics
- Published
- 2025-06-09
- DOI
- https://doi.org/10.3389/fgene.2025.1541732
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China